AIIMS Delhi starts screening of children for Covaxin trials
The screening of children for trial of Covaxin, India's first indigenously developed COVID-19 vaccine, among those aged between 2 and 18 started at the AIIMS here on Monday.
The screening of children for trial of Covaxin, India's first indigenously developed COVID-19 vaccine, among those aged between 2 and 18 started at the AIIMS here on Monday.
